The impact of physician supply on avoidable cancer deaths in Germany. A spatial analysis

Health Policy

Volumn 103, Issue 1, 2011, Pages 53-62

  Sundmacher, Leonie ^a   Busse, Reinhard ^a  

^a TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Avoidable cancer mortality; Health services; Negative binomial regression; Physician supply; Random intercepts

Indexed keywords

ANUS CANCER; ARTICLE; BINOMIAL DISTRIBUTION; BREAST CANCER; CANCER MORTALITY; CANCER PREVENTION; COLON CANCER; GERMANY; HEALTH CARE AVAILABILITY; HEALTH SERVICE; HUMAN; MEDICAL RECORD; PHYSICIAN; RECTUM CANCER; RISK FACTOR;

ANUS NEOPLASMS; BREAST NEOPLASMS; COLONIC NEOPLASMS; FEMALE; GERMANY; HUMANS; MALE; NEOPLASMS; PHYSICIANS; RECTAL NEOPLASMS; REGRESSION ANALYSIS; SEX FACTORS; SIGMOID NEOPLASMS;

EID: 80054786840     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2011.08.004     Document Type: Article

References (47)

1. Albano J.D., Ward E., Jemal A., Anderson R., Cokkinides V.E., Murray T. Cancer mortality in the United States by education level and race. Journal of the National Cancer Institute 2007, 99:1384-1394.
2. Ando M., Wakai K., Seki N., Tamakoshi A., Suzuki K., Ito Y., et al. Attributable and absolute risk of lung cancer death by smoking status: findings from the Japan Collaborative Cohort Study. International Journal of Cancer 2003, 105:249-254.
3. Cerhan J., Potter J., Gilmore J., Janney C., Kushi L., Lazovich A. Adherence to the AICR cancer prevention recommendations and subsequent morbidity and mortality in the Iowa Women's Health Study Cohort. Cancer Epidemiology Biomarkers and Prevention 2004, 13:1114-1120.
4. Coleman M.P., Babb P., Sloggett A., Quinn M., De Stavola B. Socioeconomic inequalities in cancer survival in England and Wales. Cancer 2001, 91:208-216.
5. Mandelblatt J.S., Yabroff K.R., Kerner J.F. Equitable access to cancer services: a review of barriers to quality care. Cancer 1999, 86:2378-2390.
6. Sarfati D., Hill S., Blakely T., Robson B., Purdie G., Dennett The effects of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study. BMC Cancer 2009, 9:116.
7. Wilkinson R., Pickett E. Income inequality and socioeconomic gradients in mortality. American Journal of Public Health 2008, 98:699-704.
8. Nolte E., McKee M. Measuring the health of nations: analysis of mortality amenable to health care. BMJ 2003, 327:1129.
9. Rutstein D.D., Berenberg W., Chalmers T.C., Child C.G., Fishman A.P., Perrin E.B. Measuring the quality of medical care. A clinical method. New England Journal of Medicine 1976, 294:582-588.
10. Charlton J.R., Hartley R.M., Silver R., Holland W.W. Geographical variation in mortality from conditions amenable to medical intervention in England and Wales. Lancet 1983, 1:691-696.
11. Charlton J.R., Velez R. Some international comparisons of mortality amenable to medical intervention. BMJ 1986, 292:295-301.
12. Chung J.I., Song Y.M., Choi J.S., Kim B.M. Trends in avoidable death over 20 years in Korea. Journal of Korean Medicine Science 2008, 23:975-981.
13. Holland W.W. European community atlas of avoidable death. CEC health services research 1997, vol. 1. University Press, Oxford.
14. James P.D., Manuel D.G., Mao Y. Avoidable mortality across Canada from 1975 to 1999. BMC Public Health 2006, 23:137.
15. Korda R.J., Butler J.R., Clements M.S., Kunitz S.J. Differential impacts of health care in Australia: trend analysis of socioeconomic inequalities in avoidable mortality. International Journal of Epidemiology 2007, 36:157-165.
16. Mackenbach J.P., Kunst A.E., Looman C.W., Habbema J.D., van der Maas P.J. Regional differences in mortality from conditions amenable to medical intervention in The Netherlands: a comparison of four time periods. Journal of Epidemiology and Community Health 1988, 42:325-332.
17. Poikolainen K., Eskola J. The effects of health services on mortality: decline in death rates from amenable and non-amenable causes in Finland, 1969-81. Lancet 1986, 1:199-202.
18. Song Y.M., Byeon J.J. Excess mortality from avoidable and non-avoidable causes in men of low socioeconomic status: a prospective study in Korea. Journal of Epidemiology and Community Health 2000, 54:166-172.
19. Tobias M., Jackson G. Avoidable mortality in New Zealand, 1981-97. Australian and New Zealand Journal of Public Health 2001, 25:12-20.
20. Treurniet H.F., Looman C.W., van der Maas P.J., Mackenbach J.P. Variations in 'avoidable' mortality: a reflection of variations in incidence?. International Journal of Epidemiology 1999, 28:225-232.
21. Ward J., Girgis S., Adily A. Attributable fractions for premature mortality avoidable through public health action: updated estimates by Australian public health physicians. Australian and New Zealand Journal of Public Health 2006, 30:407-412.
22. Nolte E., McKee M. Does health care save lives? Avoidable mortality revisited 2004, The Nuffield Trust, London.
23. Cremieux P., Ouellette P., Pilon C. Health care spending as determinants of health outcomes. Health Economics 1999, 8:627-639.
24. Grubaugh S., Santerre R. Comparing the performance of health care systems: an alternative approach. Southern Economic Journal 1994, 60:1030-1042.
25. Or Z., Wang J., Jamison D. International differences in the impact of doctors on health: a multilevel analysis of OECD countries. Journal of Health Economics 2005, 25:531-560.
26. Robst J., Graham G. Access to health care and current health status: do physicians matter?. Applied Economic Letters 1997, 4:45-48.
27. Robst J. A note on the relationship between medical care resources and mortality. Applied Economic Letters 2001, 8:737-739.
28. Aakvik A., Holmås T.H. Access to primary health care and health outcomes: the relationships between GP characteristics and mortality rates. Journal of Health Economics 2006, 25:1139-1153.
29. Cameron C., Trivedi P.K. Microeconometrics: methods and applications 2005, Cambridge University Press, New York.
30. Levi F., Lucchini F., Negri E., Zatonski W., Boyle P., la Vecchia C. Trends in cancer mortality in the European Union and accession countries, 1980-2000. Annuals of Oncology 2004, 15:1425-1431.
31. Vacchino M.N. Poisson regression in mapping cancer mortality. Environmental Research 1999, 81:1-17.
32. Moller P., Kjirsgaard Folkmann J., Forchhammer L., Vaclavik B., Hogh Danielson P., Risom L., et al. Air pollution, oxidative damage to DNA, and carcinogenesis. Cancer Letters 2008, 8:4-97.
33. Katz S.J., Zemencuk J.K., Hofer T.P. Breast cancer screening in the United States and Canada, 1994: socioeconomic gradients persist. American Journal of Public Health 2000, 90:799-803.
34. Marshall B., Chevalier A., Garillon C., Goldberg M., Coing F. Socioeconomic status, social mobility and cancer occurrence during working life: a case-control study among French electricity and gas workers. Cancer Causes Control 1999, 10:495-502.
35. Jemal A., Center M.M., Ward E., Thun M.J. Cancer occurrence. Methods of Molecular Biology 2009, 471:3-29.
36. Stirbu I., Kunst A.E., Bopp M., Leinsalu M., Regidor E., Esnaola S. Educational inequalities in avoidable mortality in Europe. Journal of Epidemiology and Community Health 2009, 10:1136.
37. Becker N. Entwicklung der Inzidenz und Mortalität an Brustkrebs. Radiologe 2001, 41:337-343.
38. Hirte L., Nolte E., Bain C., McKee M. Breast cancer mortality in Russia and Ukraine 1963-2002: an age-period-cohort analysis. International Journal of Epidemiology 2007, 36:900-906.
39. Dobritz J. Der demographische Wandel in Ostdeutschland-Verlauf und Erklärungsansätze. Zeitschrift für Bevölkerungswissenschaft 1997, 22:239-268.
40. Eide M.J., Weinstock M.A., Clark M.A. The association of physician density-specialty an melanoma prognosis in the United States, 1988-1993. Journal of the American Academy of Dermatology 2009, 5:1-58.
41. Scott A., Shiell A. Analysing the effect of competition on general practitioners' behaviour using a multilevel modelling framework. Health Economics 1997, 6:577-588.
42. Thode N., Bergmann E., Kamtsiuris P. Einflussfaktoren auf die Inanspruchnahme des deutschen Gesundheitswesens und mögliche Steuerungsmechanismen. Bundesgesundheitsblatt 2005, 48(3):296-306.
43. Tussing A.D., Wojtowycz M.A. Physician induced demand by Irish GPs. Social Science and Medicine 1986, 23(9):851-860.
44. Continelli T., McGinnis S., Holmes T. The effect of local primary care physician supply on the utilization of preventive health services in the United States. Health and Place 2010, 16:942-959.
45. Busse R., Riesberg A. Health care systems in transition 2004, WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies, Copenhagen, Germany.
46. Mackenbach J.P., Bouvier-Colle M.H., Jougla E. Avoidable mortality and health services: a review of aggregate data studies. Journal of Epidemiology and Community Health 1990, 44:106-111.
47. Agresti A. Categorical data analysis 1990, Wiley Press, New York.